BVF PARTNERS L P/IL Insider Trading $CALA Calithera Biosciences, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Over the past year BVF PARTNERS L P/IL has been an insider in 11 companies. The total value of shares held by BVF PARTNERS L P/IL in these companies amounts to $226,487,611.

BVF PARTNERS L P/IL 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
ARQULE INC
10% Owner
Calithera Biosciences, Inc.
Capstone Therapeutics Corp.
ChemoCentryx, Inc.
10% Owner
CONCERT PHARMACEUTICALS, INC.
Director, 10% Owner
CTI BIOPHARMA CORP
CYTOKINETICS INC
Eledon Pharmaceuticals, Inc.
FIVE PRIME THERAPEUTICS, INC.
10% Owner
GLYCOMIMETICS INC
IDEAYA Biosciences, Inc.
10% Owner
IMMUNE DESIGN CORP.
10% Owner
INFINITY PHARMACEUTICALS, INC.
Director
Kymera Therapeutics, Inc.
10% Owner
Merus N.V.
Director
Olema Pharmaceuticals, Inc.
10% Owner
PIERIS PHARMACEUTICALS, INC.
10% Owner
Principia Biopharma Inc.
Director
Rain Therapeutics Inc.
10% Owner
Syndax Pharmaceuticals Inc
10% Owner
Xenon Pharmaceuticals Inc.
Director, 10% Owner
XOMA Corp
$ 226487611 The total value of shares held by BVF PARTNERS L P/IL
Insider Rank

BVF PARTNERS L P/IL ranks 207 out of 350,000 insiders. Go to Insider Ranking to see more.

BVF PARTNERS L P/IL in Calithera Biosciences, Inc.

Trading Symbol: CALA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 3,712,340 shares
Current Value: $33,782,294
Latest Transaction: May 26 2020
$CALA Market Capitalization: $187.67M
$CALA Previous Close: $9.10

Last 4 weeks trend: BUY
Last 3 months trend: BUY

Last 3 Months Overview:
Buy: 9x
Sell: 3x
Shares Bought: 2,524,973
Shares Sold: 2,283,598
Share Difference: +241,375
Value Difference: +$6,957,971

Latest Insider Trading Transactions of BVF PARTNERS L P/IL in Calithera Biosciences, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000003
Value of Purchases ($)000000433,005
No. of Sales0000003
Value of Sales ($)00000013,701,588

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 26 2020CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerSellS6.00192,2501,153,500480,432672.7 K to 480.4 K (-28.58 %)
May 26 2020CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerSellS6.001,064,3326,385,9922,766,5613.8 M to 2.8 M (-27.78 %)
May 26 2020CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerSellS6.001,027,0166,162,0963,712,3404.7 M to 3.7 M (-21.67 %)
Nov 18 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP3.3711,10537,424658,531647.4 K to 658.5 K (+1.72 %)
Nov 18 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP3.3745,888154,6433,751,6083.7 M to 3.8 M (+1.24 %)
Nov 18 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP3.3771,495240,9384,640,8384.6 M to 4.6 M (+1.56 %)
Oct 31 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP2.7057,868156,244647,426589.6 K to 647.4 K (+9.82 %)
Oct 31 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP2.70331,048893,8303,705,7203.4 M to 3.7 M (+9.81 %)
Oct 31 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP2.70408,5921,103,1984,569,3434.2 M to 4.6 M (+9.82 %)
Oct 31 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP2.60116,552303,035589,558473 K to 589.6 K (+24.64 %)
Oct 31 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP2.60610,0521,586,1353,374,6722.8 M to 3.4 M (+22.07 %)
Oct 31 2019CALACalithera Bioscien ...BVF PARTNERS L P/IL10% OwnerBuyP2.60872,3732,268,1704,160,7513.3 M to 4.2 M (+26.53 %)

Page:   1